CLINICAL USE OF LEVODOPA AND AMANTADINE IN PARKINSONS-DISEASE

被引：0

作者：

WALKER, JE

机构：

[1] VET ADM HOSP,DALLAS,TX 75216

[2] UNIV TEXAS,HLTH SCI CTR,DALLAS,TX

来源：

CLINICAL MEDICINE | 1975年 / 82卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：27 / 29

页数：3

相关论文

共 50 条

[21] PIGMENTATION IN PARKINSONS-DISEASE TREATED WITH LEVODOPA
GRAINGER, KM
LANCET, 1973, 1 (7794) : 97 - 98
[22] DOES LEVODOPA AGGRAVATE PARKINSONS-DISEASE
BLIN, J
BONNET, AM
AGID, Y
NEUROLOGY, 1988, 38 (09) : 1410 - 1416
[23] FLUCTUATING LEVODOPA CONCENTRATIONS AND PARKINSONS-DISEASE
JUNCOS, J
SERRATI, C
FABBRINI, G
CHASE, TN
LANCET, 1985, 2 (8452) : 440 - 440
[24] EXTENDED CLINICAL TRIAL TO COMPARE LEVODOPA AND AMANTADINE USED AS SINGLE DRUGS WITH BOTH DRUGS USED IN COMBINATION IN PARKINSONS-DISEASE
CALLAGHAN, N
MCILROY, M
OCONNOR, M
IRISH JOURNAL OF MEDICAL SCIENCE, 1974, 143 (02) : 79 - 85
[25] THE IMPACT OF TREATMENT WITH LEVODOPA ON PARKINSONS-DISEASE
SHAW, KM
LEES, AJ
STERN, GM
QUARTERLY JOURNAL OF MEDICINE, 1980, 49 (195): : 283 - 293
[26] BROMOCRIPTINE IN LIEU OF LEVODOPA FOR PARKINSONS-DISEASE
WODAK, J
STARK, R
GILLIGAN, B
MEDICAL JOURNAL OF AUSTRALIA, 1978, 2 : 28 - 31
[27] PROGRESSION OF PARKINSONS-DISEASE WITHOUT LEVODOPA
GOETZ, CG
TANNER, CM
SHANNON, KM
NEUROLOGY, 1987, 37 (04) : 695 - 698
[28] COMPARISON OF THE CLINICAL-PHARMACOLOGY OF (-)NPA AND LEVODOPA IN PARKINSONS-DISEASE
MOURADIAN, MM
HEUSER, IJE
BARONTI, F
GIUFFRA, M
CONANT, K
DAVIS, TL
CHASE, TN
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1991, 54 (05) : 401 - 405
[29] METABOLIC PATTERNS AND CLINICAL RESPONSE TO LEVODOPA THERAPY IN PARKINSONS-DISEASE
MESSIHA, FS
KNOPP, W
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1973, 14 (04) : 565 - 571
[30] TRANSIENT LEVODOPA WITHDRAWAL IN PARKINSONS-DISEASE
MAESNER, JE
CLINICAL PHARMACY, 1987, 6 (01): : 22 - 22

← 1 2 3 4 5 →